Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Amplia Therapeutics Limited INNMF

Set alert

Price alert · INNMF

All alert types
0.06 USD 0.00 +6.48%

At close · Oct 30

0.0575 Day range 0.0575
0.05 52-week range 0.27
YTD
-27.22%
1 year
-28.13%
Open
0.0575
Prev close
0.054
Mkt cap
29.52M
Vol
20.00K
Avg vol
20.09K
EPS
-0.01
P/E
0.00
More statistics
Low
0.0575
High
0.0575

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for INNMF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

6.91 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -16.3×
FY 2017: -0.8×FY 2018: -1.5×FY 2019: -6.3×FY 2020: -7.5×FY 2021: -10.5×FY 2022: -5.7×FY 2023: -3.0×FY 2024: -3.3×FY 2025: -3.7×FY 2026: -16.3×
FY 2017 5y median -3.7× FY 2026
P/S 0.0×
FY 2017: 3.4×FY 2018: 11.0×FY 2019: 235×FY 2020: 487×FY 2021: 15.6×FY 2022: 10.5×FY 2023: 15.9×FY 2024: 3.4×FY 2025: 6.4×FY 2026: 0.0×
FY 2017 5y median 6.4× FY 2026
P/B 3.2×
FY 2017: 0.9×FY 2018: 2.7×FY 2019: 1.4×FY 2020: 1.9×FY 2021: 2.3×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 1.3×FY 2025: 1.1×FY 2026: 3.2×
FY 2017 5y median 1.2× FY 2026
P/FCF -14.3×
FY 2017: -1.0×FY 2018: -1.8×FY 2019: -12.0×FY 2020: -8.0×FY 2021: -8.2×FY 2022: -4.7×FY 2023: -3.6×FY 2024: -2.9×FY 2025: -3.5×FY 2026: -14.3×
FY 2017 5y median -3.6× FY 2026
EV/EBITDA -7.5×
FY 2017: -0.0×FY 2018: -1.0×FY 2019: -5.5×FY 2020: -6.9×FY 2021: -9.5×FY 2022: -2.3×FY 2023: -1.6×FY 2024: -2.9×FY 2025: -2.0×FY 2026: -7.5×
FY 2017 5y median -2.3× FY 2026
EV/Sales 0.0×
FY 2017: 0.2×FY 2018: 7.2×FY 2019: 210×FY 2020: 454×FY 2021: 14.4×FY 2022: 4.2×FY 2023: 10.0×FY 2024: 3.0×FY 2025: 3.5×FY 2026: 0.0×
FY 2017 5y median 3.5× FY 2026
FCF Yield -7.0%
FY 2017: -102.4%FY 2018: -55.5%FY 2019: -8.4%FY 2020: -12.5%FY 2021: -12.2%FY 2022: -21.2%FY 2023: -28.1%FY 2024: -34.3%FY 2025: -28.6%FY 2026: -7.0%
FY 2017 5y median -28.1% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 97.9%FY 2018: 96.5%FY 2019: 96.8%FY 2020: 97.7%FY 2021: 100.0%FY 2022: 99.8%FY 2023: 93.8%FY 2024: 90.1%FY 2025: 94.4%FY 2026: 0.0%
FY 2017 5y median 93.8% FY 2026
Operating Margin 0.0%
FY 2017: -498.8%FY 2018: -831.6%FY 2019: -3816.5%FY 2020: -6600.4%FY 2021: -148.8%FY 2022: -183.7%FY 2023: -520.3%FY 2024: -99.4%FY 2025: -172.2%FY 2026: 0.0%
FY 2017 5y median -172.2% FY 2026
Net Margin 0.0%
FY 2017: -393.5%FY 2018: -740.6%FY 2019: -3704.8%FY 2020: -6484.6%FY 2021: -148.8%FY 2022: -183.7%FY 2023: -524.8%FY 2024: -101.1%FY 2025: -173.7%FY 2026: 0.0%
FY 2017 5y median -173.7% FY 2026
ROE -19.5%
FY 2017: -106.7%FY 2018: -181.8%FY 2019: -21.6%FY 2020: -25.8%FY 2021: -22.1%FY 2022: -16.7%FY 2023: -39.4%FY 2024: -39.4%FY 2025: -31.3%FY 2026: -19.5%
FY 2017 5y median -31.3% FY 2026
ROIC -20.4%
FY 2017: -107.9%FY 2018: -204.1%FY 2019: -21.6%FY 2020: -25.9%FY 2021: -22.1%FY 2022: -15.2%FY 2023: -34.2%FY 2024: -17.1%FY 2025: -30.9%FY 2026: -20.4%
FY 2017 5y median -20.4% FY 2026
ROA -18.6%
FY 2017: -93.9%FY 2018: -162.6%FY 2019: -20.3%FY 2020: -24.3%FY 2021: -21.0%FY 2022: -14.9%FY 2023: -33.4%FY 2024: -30.3%FY 2025: -28.7%FY 2026: -18.6%
FY 2017 5y median -28.7% FY 2026

Growth (YoY)

Revenue -100.0%
FY 2017: -20.6%FY 2018: -67.7%FY 2019: -91.3%FY 2020: -32.2%FY 2021: 4380.4%FY 2022: 29.3%FY 2023: -40.0%FY 2024: 274.3%FY 2025: -15.0%FY 2026: -100.0%
FY 2017 FY 2026
Operating Income -102.7%
FY 2017: -22.7%FY 2018: 46.2%FY 2019: 60.1%FY 2020: -17.3%FY 2021: -1.0%FY 2022: -59.7%FY 2023: -69.9%FY 2024: 28.5%FY 2025: -47.3%FY 2026: -102.7%
FY 2017 FY 2026
EPS (diluted) 23.4%
FY 2017: -25.0%FY 2018: 43.3%FY 2019: 74.6%FY 2020: 2.8%FY 2021: 43.2%FY 2022: -5.0%FY 2023: -28.8%FY 2024: 28.0%FY 2025: 7.8%FY 2026: 23.4%
FY 2017 FY 2026
Free Cash Flow -27.5%
FY 2017: -30.6%FY 2018: 42.8%FY 2019: 72.1%FY 2020: -110.8%FY 2021: -39.9%FY 2022: -51.2%FY 2023: -20.2%FY 2024: 3.4%FY 2025: -34.3%FY 2026: -27.5%
FY 2017 FY 2026

Financial Health

Current Ratio 19.8×
FY 2017: 8.1×FY 2018: 9.5×FY 2019: 2.4×FY 2020: 2.3×FY 2021: 5.4×FY 2022: 31.2×FY 2023: 3.8×FY 2024: 2.0×FY 2025: 7.9×FY 2026: 19.8×
FY 2017 5y median 7.9× FY 2026
Quick Ratio 19.8×
FY 2017: 8.1×FY 2018: 9.5×FY 2019: 2.4×FY 2020: 2.3×FY 2021: 5.4×FY 2022: 31.2×FY 2023: 3.8×FY 2024: 2.0×FY 2025: 7.9×FY 2026: 19.8×
FY 2017 5y median 7.9× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 2.1×
FY 2017: 0.8×FY 2018: 0.5×FY 2019: 0.6×FY 2020: 0.5×FY 2021: 0.8×FY 2022: 3.4×FY 2023: 1.0×FY 2024: 0.4×FY 2025: 1.6×FY 2026: 2.1×
FY 2017 5y median 1.6× FY 2026
Interest Coverage -759×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -3168×FY 2023: -115×FY 2024: -56.4×FY 2025: 0.0×FY 2026: -759×
FY 2017 5y median -115× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31